Key Segments:
By Component
-
Software
-
Hardware
-
Services
By Application
-
Diagnosis
-
Prediction
-
Drug Discovery
-
Others
By Medical Condition
-
Ischemic Heart Disease
-
Cardiac Arrhythmias
-
Heart Failure
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes GE HealthCare, Philips, Siemens Healthineers, Canon Medical Systems, Medtronic, Viz.ai, HeartFlow, Cleerly, Ultromics, Eko Health, AliveCor, Anumana, iRhythm Technologies, Boston Scientific, Idoven, Implicity, and Circle Cardiovascular Imaging, among others.
The main opportunities lie in new reimbursement codes for AI-assisted cardiac services and expansion into underserved markets across Asia Pacific, the Middle East, Africa and Latin America, where specialist cardiologists remain scarce relative to patient populations.
The key growth factor is the combination of a rising cardiovascular disease burden and a persistent shortage of cardiologists and sonographers, which pushes hospitals toward AI tools that triage, diagnose and predict cardiac disease at scale.
By component, the Hardware segment dominated the market with approximately 37.40% share in 2025, as AI capability remains most often bundled into imaging equipment rather than sold as standalone software.
North America dominated the market with approximately 44.85% share in 2025, supported by dense academic medical centers and early regulatory clearance activity. Asia Pacific is the fastest-growing region with a projected CAGR of 33.80% from 2026 to 2035.
